Media

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim Report Q1 2022

Invitation to presentation of Q1 report

Fusion Pharmaceuticals To Present At The 2022 Bloom Burton & Co. Healthcare Investor Conference

Carisma Therapeutics Announces Appointment Of Michael Klichinsky, PharmD, PhD, As Chief Scientific Officer

Priothera Receives FDA clearance of Investigational New Drug (IND) to start Phase 2b/3 study with mocravimod in Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Priothera to present an abstract at the TANDEM Meetings / Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR – April 23-26 2022

Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety in patients with idiopathic pulmonary fibrosis (IPF)

Oncopeptides publishes the 2021 Annual Report